Skip to main content
Premium Trial:

Request an Annual Quote

Biocept: M. Faye Wilson, Bruce Gerhardt, Marsha Chandler

Biocept board chair M. Faye Wilson unexpectedly passed away on July 10. She was appointed to the firm's board in 2009 and at different times served as lead independent director. Most recently, she was a member of the audit, compensation, and science and technology committees. Wilson was CEO of business consulting firm Wilson Boyles. Before that, she was senior VP at The Home Depot, and prior to that, she worked at Bank of America.

Biocept has appointed Bruce Gerhardt as its new board chair and Marsha Chandler as vice chair. Gerhardt is a tax and business advisor for businesses and individuals. He previously worked as financial VP for several companies and joined the Biocept board in 2010. Chandler, who joined the board in 2013, is senior vice chancellor and professor emerita at the University of California, San Diego School of Global Policy and Strategy as well as advisor to the Lehigh University College of Global Health and the University of Texas at Austin's Jackson School of Geosciences and College of Pharmaceutical Sciences. She previously served as executive VP and chief operating officer of the Salk Institute for Biological Studies and as senior vice chancellor for academic affairs at UCSD.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.